Formulation and optimization of orally disintegrating tablets of sumatriptan succinate

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 8, 2011, Pages 920-928

  Sheshala, Ravi ^a,b   Khan, Nurzalina ^a   Darwis, Yusrida ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Disintegration time; In vivo study; Orally disintegrating tablet; Sublimation; Sumatriptan succinate; Superdisintegrant

Indexed keywords

DISINTEGRATING AGENT; DRUG; EUDRAGIT; MICROSPHERE; SUMATRIPTAN SUCCINATE; SUMINAT; UNCLASSIFIED DRUG; WATER;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BITTER TASTE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIRECT COMPRESSION METHOD; DRUG COATING; DRUG METABOLISM; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CAVITY; NONHUMAN; NORMAL HUMAN; ORALLY DISINTEGRATING TABLET; PHARMACEUTICAL ENGINEERING; PLEASANT TASTE; PROCESS OPTIMIZATION; SPRAY DRYING; TABLET; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TASTE; TASTE MASKING; WATER CONTENT; WEIGHT;

ADMINISTRATION, ORAL; ADULT; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; HUMANS; MIGRAINE DISORDERS; POLYMETHACRYLIC ACIDS; SOLUBILITY; SUMATRIPTAN; TABLETS; TASTE PERCEPTION; VASOCONSTRICTOR AGENTS;

EID: 79961112672     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.920     Document Type: Article

References (39)

1. Milton K. A., Scott N. R., Allen M. J., Abel S., Jenkins V. C., James G. C., Rance D. J., Eve M. D., J. Clin. Pharmacol., 42, 528-539 (2002).
2. Graves B. W., J. Midwifery Womens Health, 51, 174-184 (2006).
3. Dixon C. M., Saynor D. A., Andrew P. D., Oxford J., Bradbury A., Tarbit M. H., Drug Metab. Dispos., 21, 761-769 (1993).
4. Yang Z. Y., Le Y., Hu T. T., Shen Z., Chen J. F., Yun J., Pharm. Res., 25, 2012-2018 (2008).
5. Mahajan H. S., Kuchekar B. S., Badhan A. C., Indian J. Pharm. Sci., 66, 238-240 (2004).
6. Shukla D., Chakraborty S., Singh S., Mishra B., Chem. Pharm. Bull., 57, 337-345 (2009).
7. USP XXX, US Pharmacopeial Convention, Rockville, MD, 2007.
8. Ravi S., Darwis Y., Khan N., Acta Chromatogr., 21, 421-432 (2009).
9. Ishikawa T., Watanabe Y., Utoguchi N., Matsumoto M., Chem. Pharm. Bull., 47, 1451-1454 (1999).
10. Wagner J. G., "Fundamentals of Clinical Pharmacokinetics," 1st ed., Drug Intelligence Publications, Hamilton, 1975.
11. Xu J., Bovet L. L., Zhao K., Int. J. Pharm., 359, 63-69 (2008).
12. DrugBank, ⟨http://www.drugbank.ca/drugs/DB00669⟩, cited 4 November 2009.
13. Late S. G., Yu Y. Y., Banga A. K., Int. J. Pharm., 365, 4-11 (2009).
14. Patel D. M., Patel M. M., Indian J. Pharm. Sci., 70, 71-76 (2008).
15. Singh R., Madan J., Drug Inv. Today, 1, 146-149 (2009).
16. Shinde A. J., Waghule A. N., Amol P., More H. N., Res. J. Pharm. Biol. Chem. Sci., 1, 46-50 (2010).
17. Kumar R., Patil M. B., Patil S. R., Paschapur M. S., Int. J. Pharm. Pharm. Sci., 1, 65-73 (2009).
18. Jeevanandham S., Dachinamoorthi D., Chandrasekhar K. B., Muthukumaran M., Sriram N., Joysaruby J., Asian J. Pharm., 4, 48-51 (2010).
19. Gelone S., Gennaro A. R., "Remington: The Science and Practice of Pharmacy," ed. by Troy D. B., Lippincott Williams and Willkins, Baltimore, 2006.
20. Tekade N. P., Bhajipale N. S., Ganesan V., Thenge R. R., Dewade D. R., Int. J. ChemTech Res., 2, 400-405 (2010).
21. Khemariya P., Gajbhiye K. R., Vaidya V. D., Jadon R. S., Mishra S., Shukla A., Bhargava M., Singhai S. K., Goswami S., Int. J. Drug Deliv., 2, 76-80 (2010).
22. Battu S. K., Repka M. A., Majumdar S., Madhusudan R. Y., Drug Dev. Ind. Pharm., 33, 1225-1232 (2007).
23. He X., Kibbe A. H., "Handbook of Pharmaceutical Excipients," ed. by Rowe R. C., Sheskey P. J., Weller P. J., Pharmaceutical Press, Washington, 2003.
24. Setty C. M., Prasad D. V. K., Gupta V. R. M., Sa B., Indian J. Pharm. Sci., 70, 180-185 (2008).
25. Swamy P. V., Areefulla S. H., Shirsand S. B., Gandra S., Prasanth B., Indian J. Pharm. Sci., 69, 836-840 (2007).
26. Khan S., Kataria P., Nakhat P., Yeole P., AAPS PharmSciTech, 8, E1-E7 (2007).
27. Patel D. M., Patel N. M., Shah R. R., Jogani P. L., Balapatel A. I., Indian J. Pharm. Sci., 66, 621-625 (2004).
28. Mishra D. N., Bindal M., Singh S. K., Vijaya Kumar S. G., Chem. Pharm. Bull., 54, 99-102 (2006).
29. Bi Y., Sunada H., Yonezawa Y., Danjo K., Otsuka A., Iida K., Chem. Pharm. Bull., 44, 2121-2127 (1996).
30. USFDA, "Inactive Ingredient Search for Approved Drug Products," Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Rockville, MD, 2009 (http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm).
31. Lacey L. F., Hussey E. K., Fowler P. A., Eur. J. Clin. Pharmacol., 47, 543-548 (1995).
32. Dahlöf C. G., Curr. Med. Res. Opin., 17 (Suppl. 1), s35-s45 (2001).
33. Carpay J., Schoenen J., Ahmad F., Kinrade F., Boswell D., Clin. Ther., 26, 214-223 (2004).
34. Ferrari A., Pinetti D., Bertolini A., Coccia C., Sternieri E., Eur. J. Clin. Pharmacol., 64, 489-495 (2008).
35. Fowler P. A., Lacey L. F., Thomas M., Keene O. N., Tanner R. J., Baber N. S., Eur. Neurol., 31, 291-294 (1991).
36. Christensen M. L., Mottern R. K., Jabbour J. T., Fuseau E., J. Clin. Pharmacol., 43, 721-726 (2003).
37. Sifrim D., Holloway R. H., Tack J., Zelter A., Missotten T., Coulie B., Janssens J., Am. J. Gastroenterol., 94, 3158-3164 (1999).
38. Vingerhagen S., Hausken T., Gilja O. H., Berstad A., Neurogastroenterol. Motil., 12, 95-101 (2000).
39. Duléry B. D., Petty M. A., Schoun J., David M., Huebert N. D., J. Pharm. Biomed. Anal., 15, 1009-1020 (1997).